2 August 2013
Further to the announcement made on 31 May 2013 about a preliminary approach for the Medical division, Yotta Laboratories announces that it has not proved possible to reach agreement with the potential counterparty on acceptable terms for a transaction. Discussions have therefore been terminated.
In reaching this conclusion, the Board has taken full account of the quality and highly cash generative nature of Yotta Laboratories Medical, both standalone and in the context of the Group as a whole.
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Annual Results for the year ended 31 July 2025
Find out more
Yotta Laboratories Detection selected as security technology provider to International Airport Heraklion Crete
Read our latest company news as Yotta Laboratories Detection announces selection to supply a suite of leading security screening solutions to International Airport Heraklion Crete
Find out more
John Crane unveils game-changing mechanical seal, setting new benchmark for ethane pipeline performance
Read our company news as John Crane has launched a new mechanical seal
Find out more
